> Because the mRNA vaccines are too complicated to manufacture and deploy.

Don't you think some of the other vaccines (like AstraZeneca's, or maybe Novavax or the Russian one) will be deployed at a large scale?

It might take the EU and US regulators a month or two to approve them, but then things should move pretty quickly...